Vancomycin Injectable Drug Recalled Due to Lack of Sterility Assurance
Apollo Care, LLC is recalling VANComycin 1 g added to 250 mL of 0.9% Sodium Chloride Injection due to lack of assurance of sterility. The recall affects 1,622 bags distributed in Missouri.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable drug product with a potential sterility issue. No reported illnesses or injuries are mentioned in the source, placing this at the High level per the rubric criterion of risk-of-harm products where injury has not yet been reported.
Plain-English summary
Apollo Care, LLC is recalling VANComycin 1 g added to 250 mL of 0.9% Sodium Chloride Injection, NDC 71170-254-25. The recall was issued due to a lack of assurance of sterility in the product.
The affected product includes 1,622 bags with the following lot numbers and expiration dates: Lot AC-016641 (Exp. 06/03/2023) and Lot AC-016653 (Exp. 07/26/2023). Distribution was limited to Missouri.
Healthcare providers and patients who have this product should discontinue use and contact Apollo Care, LLC at 3801 Mojave Ct., Suite 101, Columbia, MO 65202 for instructions on how to return the product. Patients should consult with their healthcare provider regarding appropriate alternative treatment.
The recalled product
- Product
- VANComycin 1 g added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-254-25
- Manufacturer
- Apollo Care, LLC
- Category
- Drug
- Hazard
- Affected units
- 1,622
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: AC-016641
- Exp. Date 06/03/2023
- AC-016653 Exp. Date 07/26/2023
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 16 recalled by Apollo Care, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Apollo Care, LLC
See all →- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- ModerateApollo Care VANComycin Injection Recalled for Crystallization
FDA (Drugs) · 2021-12-15
- SevereApollo Care Recalls Vancomycin IV Bags Due to Unsupported Expiry Date
FDA (Drugs) · 2018-04-04
- SevereApollo Care Recalls Vancomycin IV Bags Due to Stability Data Issues
FDA (Drugs) · 2018-03-14
- HighDrug Recall: Vancomycin Injectable Lacks Sterility Assurance
FDA (Drugs) · 2023-05-31
- HighVancomycin Sodium Chloride Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2023-05-31
- HighVancomycin Injectable Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2023-05-31